α1-adrenoceptor antagonists, also known as α-blockers, are widely used in men with certain types of lower urinary tract symptoms (LUTS), although use of such agents alone often fails to address the symptoms of nocturia. The findings of a newly published randomized controlled study reveal that the addition of desmopressin to α-blocker monotherapy in men 40–65 years of age with LUTS and persistent nocturia is safe and effective. Significant improvements in the mean number of nocturia episodes and nocturnal urine volume, relative to those of men with similar symptoms who received α-blocker monotherapy, were observed.
References
Kim, J. C. et al. Efficacy and safety of desmopressin “add-on” therapy in men with persistent nocturia under alpha blocker monotherapy for lower urinary tract symptoms: a randomized, double-blind, placebo-controlled study. J. Urol. http://dx.doi.org/10.1016/j.juro.2016.08.116 (2016)
Rights and permissions
About this article
Cite this article
Sidaway, P. Use of α-blockers plus desmopressin is safe. Nat Rev Urol 13, 632 (2016). https://doi.org/10.1038/nrurol.2016.189
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2016.189